Search

everythinglearnresearchcommunity

for

Search:↓

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Aromatase inhibitors cause male pattern hair loss in women.

Androgenetic Alopecia is commonly known as male or female pattern baldness.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Most men seeking hair transplants have Male Pattern Baldness, influenced by genetics, age, and testosterone, while women's hair loss can be affected by thyroid function, iron, testosterone, prolactin, ferritin levels, and certain conditions. Follicular Unit Extraction is a popular hair transplant technique.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Androgenic alopecia is male or female pattern baldness.

The document concludes that signs of male and female pattern baldness include uneven hair thickness, yellow spots, skin discoloration around hair follicles, more thin and soft hairs, and many hair follicles with just one hair.

Androgenic Alopecia is commonly known as male or female pattern baldness.

AGA more common in men, Koreans have lower rates and unique patterns.

Female and male AGA are different diseases.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Baldness might be caused by scalp weight pressing on hair follicles.

A new technique called hair-lifting was introduced to treat male-pattern baldness and can also give a partial face-lift.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Female pattern hair loss in Thailand varies by region and demographics, affecting diagnosis and treatment.

AI can predict hair loss patterns to improve care and treatment.

Targeting IL-17 could help treat pattern hair loss.

Combination therapy with higher concentrations of minoxidil can lead to rapid hair growth in pattern baldness with no significant side effects.

Androgenic alopecia (AA) in Indian women is rarely reported, with varying severity and patterns, and hair pull tests and trichograms help understand it better.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Hair transplantation, especially follicular unit micrografting, was the top treatment for male pattern baldness, with a focus on natural results and ongoing improvements in both surgical and medical management.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

PRP injections improve hair thickness for baldness.